Given its common high expression in malignant cancer cells, CD47 is associated with a poor clinical prognosis and metastasis and is thus considered a potential therapeutic target (Baccelli et al., 2014; Majeti et al., 2009; Wang et al., 2013; Willingham et al., 2012). This evidence concerns the gene CD47 and cancer.